CorVel Co. (NASDAQ:CRVL) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in CorVel Co. (NASDAQ:CRVL - Free Report) by 212.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,144 shares of the business services provider's stock after purchasing an additional 10,295 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in CorVel were worth $1,685,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CRVL. Barclays PLC boosted its position in shares of CorVel by 380.8% during the 3rd quarter. Barclays PLC now owns 15,977 shares of the business services provider's stock valued at $5,223,000 after acquiring an additional 12,654 shares during the last quarter. Ballentine Partners LLC boosted its position in shares of CorVel by 211.0% during the 4th quarter. Ballentine Partners LLC now owns 2,429 shares of the business services provider's stock valued at $270,000 after acquiring an additional 1,648 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of CorVel by 217.1% during the 4th quarter. Nisa Investment Advisors LLC now owns 555 shares of the business services provider's stock valued at $62,000 after acquiring an additional 380 shares during the last quarter. SG Americas Securities LLC boosted its position in shares of CorVel by 322.2% during the 4th quarter. SG Americas Securities LLC now owns 1,520 shares of the business services provider's stock valued at $169,000 after acquiring an additional 1,160 shares during the last quarter. Finally, Wesbanco Bank Inc. lifted its position in CorVel by 193.4% in the fourth quarter. Wesbanco Bank Inc. now owns 7,731 shares of the business services provider's stock worth $860,000 after buying an additional 5,096 shares during the last quarter. 51.36% of the stock is currently owned by institutional investors.

CorVel Stock Performance

CRVL stock traded up $0.96 during midday trading on Thursday, reaching $111.40. The company's stock had a trading volume of 11,351 shares, compared to its average volume of 122,547. The stock has a fifty day simple moving average of $112.18 and a two-hundred day simple moving average of $116.60. CorVel Co. has a 1 year low of $76.53 and a 1 year high of $128.61. The firm has a market capitalization of $5.72 billion, a price-to-earnings ratio of 65.53 and a beta of 1.10.

CorVel (NASDAQ:CRVL - Get Free Report) last released its earnings results on Thursday, May 22nd. The business services provider reported $0.51 earnings per share for the quarter. The business had revenue of $231.51 million for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded CorVel from a "hold" rating to a "buy" rating in a research report on Friday, April 18th.

Insider Activity

In other CorVel news, Director Jeffrey J. Michael sold 16,523 shares of CorVel stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $116.99, for a total value of $1,933,025.77. Following the transaction, the director now owns 551,787 shares in the company, valued at $64,553,561.13. The trade was a 2.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 47.57% of the company's stock.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.